Prognostic significance of electrophysiological study in drug-induced type-1 Brugada syndrome: a brief systematic review

J Cardiovasc Med (Hagerstown). 2024 Nov 1;25(11):775-780. doi: 10.2459/JCM.0000000000001665. Epub 2024 Sep 13.

Abstract

Background: Risk stratification in drug-induced type-1 Brugada syndrome (BrS) patients is challenging. The role of electrophysiological study (EPS) is debated as the majority of drug-induced type-1 BrS patients would not be studied according to the latest recommendations.

Methods: A complete systematic literature search was performed to gauge the EPS role in this population. Three subgroups were defined: positive-EPS group, negative-EPS group, no-EPS group.

Results: Among 1318 drug-induced type-1 BrS patients, no significant difference in the incidence rate of arrhythmic events was observed between groups (I2 = 45%, P for subgroup difference = 0.10) during a mean follow-up of 5.1 years, also considering symptomatic status.

Conclusion: In long-term follow-up of drug-induced type-1 BrS patients, EPS does not seem to aid prognostic stratification.

Publication types

  • Systematic Review

MeSH terms

  • Action Potentials / drug effects
  • Brugada Syndrome* / chemically induced
  • Brugada Syndrome* / diagnosis
  • Brugada Syndrome* / physiopathology
  • Electrocardiography
  • Electrophysiologic Techniques, Cardiac
  • Female
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prognosis
  • Risk Assessment
  • Risk Factors